GCM2 and hypoparathyroidism: Although the patient had no family history of the disease or other features suggestive of genetic abnormalities, genetic testing revealed a novel de novo heterozygous frameshift pathogenic variant of GCM2 that contributed to the development of hypoparathyroidism.